Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
Elevated levels of low-density lipoprotein (LDL-X) cholesterol, apolipoprotein B (ApoB), and especially oxidized LDL in plasma are associated with an increased risk of cardiovascular disease (CVD). The aim of the study was to determine the levels of ApoB and oxLDL in the blood of patients with dia...
Saved in:
| Published in: | Доповіді НАН України |
|---|---|
| Date: | 2021 |
| Main Authors: | Tronko, M.D., Cherviakova, S.A., Pushkarev, V.V., Belchina, Y.B., Kovzun, O.I., Pushkarev, V.M., Sokolova, L.K. |
| Format: | Article |
| Language: | English |
| Published: |
Видавничий дім "Академперіодика" НАН України
2021
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/184825 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19 / M.D. Tronko, S.A. Cherviakova, V.V. Pushkarev, Y.B. Belchina, O.I. Kovzun, V.M. Pushkarev, L.K. Sokolova // Доповіді Національної академії наук України. — 2021. — № 6. — С. 126-130. — Бібліогр.: 12 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease
by: V. V. Pushkarov, et al.
Published: (2021)
by: V. V. Pushkarov, et al.
Published: (2021)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Effect of combined treatment with insulin and metformin on 5′AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018)
by: Sokolova, L.K., et al.
Published: (2018)
Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2022)
by: M. D. Tronko, et al.
Published: (2022)
Bradykinin content in the blood of patients with COVID-19 and diabetes mellitus
by: M. D. Tronko, et al.
Published: (2024)
by: M. D. Tronko, et al.
Published: (2024)
NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment
by: Sokolova, L.K., et al.
Published: (2018)
by: Sokolova, L.K., et al.
Published: (2018)
Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018)
by: Sokolova, L.K., et al.
Published: (2018)
Glycemic control in prevention of cardiovascular diseases in diabetes mellitus
by: A. N. Korzh
Published: (2019)
by: A. N. Korzh
Published: (2019)
NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
Effect of combined trea tment with insulin and metformin on 5'AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
Cardiovascular disease among patients with type 2 diabetes: Role of homocysteine as an inflammatory marker
by: A. Sahu, et al.
Published: (2016)
by: A. Sahu, et al.
Published: (2016)
Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
Women’s Health and Cardiovascular Diseases
Published: (2012)
Published: (2012)
Women’s Health and Cardiovascular Diseases
Published: (2012)
Published: (2012)
Untitled
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Identification of genes involved in cardiovascular diseases
by: D. Abdusa
Published: (2016)
by: D. Abdusa
Published: (2016)
Prospects of gene therapy for the treatment of cardiovascular diseases
by: A. K. Gulevskij, et al.
Published: (2012)
by: A. K. Gulevskij, et al.
Published: (2012)
The role of apelin in the pathogenesis of cardiovascular and gastrointestinal diseases
by: V. P. Sinelnik
Published: (2015)
by: V. P. Sinelnik
Published: (2015)
Cardiovascular complications in COVID-19: case report and concise review
by: N. Oryshchyn, et al.
Published: (2020)
by: N. Oryshchyn, et al.
Published: (2020)
MARK activation in human blood mononuclear cells in types 1 and 2 diabetes
by: V. V. Pushkarov, et al.
Published: (2020)
by: V. V. Pushkarov, et al.
Published: (2020)
Activation of the PI3K/Akt/mTOR/p70S6K1 signaling cascade in peripheral blood mononuclear cells in patients with type 2 diabetes
by: T. S. Vatseba, et al.
Published: (2020)
by: T. S. Vatseba, et al.
Published: (2020)
The activity of adenosine monophosphate-activated protein kinase in lymphocytes under the action of hypoglycemic drugs
by: L. K. Sokolova, et al.
Published: (2017)
by: L. K. Sokolova, et al.
Published: (2017)
Endothelium and endothelial dysfunction - health implications and risk for cardiovascular diseases
by: Rutowski, J.A., et al.
Published: (2012)
by: Rutowski, J.A., et al.
Published: (2012)
The problem of adherence to long-term treatment of patients with cardiovascular diseases
by: E. A. Naumova, et al.
Published: (2014)
by: E. A. Naumova, et al.
Published: (2014)
Prospects for the use of umbilical cord blood in the treatment of diseases of the cardiovascular system
by: I. Y. Shchenyavskyi
Published: (2023)
by: I. Y. Shchenyavskyi
Published: (2023)
Biochemical effects of combined action of γ-irradiation and paclitaxel on anaplastic thyroid cancer cells
by: V. M. Pushkarev, et al.
Published: (2013)
by: V. M. Pushkarev, et al.
Published: (2013)
Phosphorylation of PRAS40 in leukocytes of patients with cancer and diabetes
by: T. S. Vatseba, et al.
Published: (2019)
by: T. S. Vatseba, et al.
Published: (2019)
The role of the interaction of risk factors in the formation of the probability of fatal outcome of cardiovascular diseases
by: E. A. Jakimenko, et al.
Published: (2016)
by: E. A. Jakimenko, et al.
Published: (2016)
Cardiovascular disease risk factors for women. A life course-events perspective
by: Hobel, C.J., et al.
Published: (2010)
by: Hobel, C.J., et al.
Published: (2010)
Small Animal Models of Cardiovascular Disease for Evaluating the Cholesterol-Lowering Activity of Probiotic Strains
by: Starovoitova, S.O., et al.
Published: (2025)
by: Starovoitova, S.O., et al.
Published: (2025)
Determination of groups of risks at the diseases COVID-19
by: A. A. Vagis, et al.
Published: (2021)
by: A. A. Vagis, et al.
Published: (2021)
Determination of Groups of Risks at the Diseases COVID-19
by: O. A. Vahis, et al.
Published: (2020)
by: O. A. Vahis, et al.
Published: (2020)
Biochemical aspects of the combined use of taxanes, irradiation and other antineoplastic agents for the treatment of anaplastic thyroid carcinoma
by: V. M. Pushkarev, et al.
Published: (2018)
by: V. M. Pushkarev, et al.
Published: (2018)
Inhibitor of the transcription factor NF-кB, DHMEQ, enhances the effect of paclitaxel on cells of anaplastic thyroid carcinoma in vitro and in vivo
by: V. V. Pushkarev, et al.
Published: (2015)
by: V. V. Pushkarev, et al.
Published: (2015)
The role of connexin 37 gene polymorphism (1019C > T; Pro319Ser) in cardiovascular disease
by: Pitha, J., et al.
Published: (2011)
by: Pitha, J., et al.
Published: (2011)
Role of Probiotics in the Prevention and Management of Cardiovascular Diseases: Insights from a Doxorubicin-Induced Model
by: Starovoitova, S.O., et al.
Published: (2025)
by: Starovoitova, S.O., et al.
Published: (2025)
D-dimer as a potential predictor of thromboembolic and cardiovascular complications in patients with chronic kidney disease
by: I. S. Mykhaloiko, et al.
Published: (2020)
by: I. S. Mykhaloiko, et al.
Published: (2020)
Similar Items
-
Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease
by: V. V. Pushkarov, et al.
Published: (2021) -
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021) -
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021) -
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021) -
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2021)